10 Publikationen
-
2024 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2991561
Human papillomavirus-associated head and neck squamous cell carcinoma cells lose viability during triggered myocyte lineage differentiationPUB | PDF | DOI | WoS | PubMed | Europe PMC
Gendreizig S, Martínez-Ruiz L, López-Rodríguez A, Pabla H, Hose L, Brasch F, Busche T, Escames G, Sudhoff H, Scholtz L-U, Todt I, et al. (2024)
Cell Death & Disease 15(7): 517. -
2024 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2993270Mucosa-like differentiation of head and neck cancer cells is inducible and drives the epigenetic loss of cell malignancyPUB | DOI | WoS | PubMed | Europe PMC
Oppel F, Gendreizig S, Martinez-Ruiz L, Florido J, López-Rodríguez A, Pabla H, Loganathan L, Hose L, Kühnel P, Schmidt P, Schürmann M, et al. (2024)
Cell Death & Disease 15(10): 724. -
2024 | Preprint | Veröffentlicht | PUB-ID: 2991403HPV-positive head and neck squamous cell carcinoma cells lose viability during triggered myocyte lineage differentiationPUB | DOI
Gendreizig S, Martinez-Ruiz L, López-Rodríguez A, Pabla H, Hose L, Brasch F, Busche T, Escames G, Sudhoff H, Scholtz L-U, Todt I, et al. (2024)
bioRxiv. -
2023 | Preprint | Veröffentlicht | PUB-ID: 2991402Inducible mucosa-like differentiation of head and neck cancer cells drives the epigenetically determined loss of cell malignancyPUB | DOI
Oppel F, Gendreizig S, Martinez-Ruiz L, Florido J, López-Rodríguez A, Pabla H, Loganathan L, Hose L, Kühnel P, Schmidt P, Schürmann M, et al. (2023)
bioRxiv. -
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2977978Recurrent Respiratory Papillomatosis (RRP)—Meta-analyses on the use of the HPV vaccine as adjuvant therapyPUB | DOI | WoS | PubMed | Europe PMC
Goon P, Sauzet O, Schuermann M, Oppel F, Shao SY, Scholtz L-U, Sudhoff H, Goerner M (2023)
npj Vaccines 8(1): 49. -
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2968186
Primary head and neck cancer cell cultures are susceptible to proliferation of Epstein-Barr virus infected lymphocytesPUB | PDF | DOI | WoS | PubMed | Europe PMC
Shao S, Scholtz L-U, Gendreizig S, Martínez-Ruiz L, Florido J, Escames G, Schürmann M, Hain C, Hose L, Mentz A, Schmidt P, et al. (2023)
BMC Cancer 23(1): 47. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2965718Head and neck cancer cells can differentiate and resemble their tissue of originPUB | DOI | WoS
Oppel F, Shao S, Gendreizig S, Kühnel P, Przybycin V, Hain C, Schmidt P, Schürmann M, Goon P, Niehaus K, Kalinowski J, et al. (2022)
In: Proceedings: AACR Annual Meeting 2022; April 8-13, 2022; New Orleans, LA. Cancer Research, 82(12_Supplement). American Association for Cancer Research (AACR): 111-111. -
2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2967816P35 Spatial proteomics and metabolomics investigations in head & neck cancersPUB | DOI | WoS
Gendreizig S, Neumann JM, Loganathan L, Hose L, Goon P, Oppel F, Brasch F, Niehaus K, Sudhoff H (2022)
Oral Oncology 134: 106164. -
2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2965703p53 pathway inactivation drives SMARCB1-deficient p53-wildtype epithelioid sarcoma onset indicating therapeutic vulnerability through MDM2 inhibitionPUB | DOI | WoS | PubMed | Europe PMC
Oppel F, Shao S, Gendreizig S, Zimmerman MW, Schürmann M, Viyof Ful F, Goon P, Chi SN, Aster JC, Sudhoff H, Look AT (2022)
Molecular Cancer Therapeutics. -
2020 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2951607The Potential of Tumor Debulking to Support Molecular Targeted TherapiesPUB | DOI | WoS | PubMed | Europe PMC
Oppel F, Görner M, Sudhoff H (2020)
Frontiers in Oncology 10: 801.